Real-time enrollment status for this biliary tract cancer clinical trial
Current Status
Active, Not Recruiting
Checked: April 17, 2026 at 3:42 AM UTC
| NCT Number | NCT06109779 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Biliary Tract Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 750 participants |
| Active Locations | 34 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | March 4, 2026 (Mar 4, 2026) |
As of April 17, 2026: Clinical trial NCT06109779 is currently active_not_recruiting participants. This clinical trial study for biliary tract cancer is not currently accepting new participants at 34 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06109779 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 34 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06109779 was last updated Mar 4, 2026 (March 4, 2026). HelloStudys verifies this status automatically.